- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
KERA Antibody (C-term)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP12617b | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP12617b-ev20 | Ev20 size 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
KERA Antibody (C-term) - Product info | |
| Application | WB
|
| Primary Accession | O60938 |
| Other Accession | NP_008966.1 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 40509 Da |
KERA Antibody (C-term) - Additional info | |
| Gene ID 11081 | |
| Other Names KERA; SLRR2B; Keratocan; Keratan sulfate proteoglycan keratocan | |
| Target/Specificity This KERA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 227-257 amino acids from the C-terminal region of human KERA. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions KERA Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
KERA Antibody (C-term) - Protein Information | |
| Name KERA | |
| Synonyms SLRR2B | |
| Function May be important in developing and maintaining corneal transparency and for the structure of the stromal matrix | |
| Cellular Location Secreted, extracellular space, extracellular matrix (By similarity) | |
| Tissue Location Cornea. Increased expression in the stroma of keratoconus corneas. Also detected in trachea, and in low levels, in intestine, skeletal muscle, ovary, lung and putamen | |
KERA Antibody (C-term) - Related products
KERA Antibody (C-term) - Application data
-
KERA Antibody (C-term) (Cat. #AP12617b) western blot analysis in MDA-MB435 cell line lysates (35ug/lane).This demonstrates the KERA antibody detected the KERA protein (arrow).
KERA Antibody (C-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
The protein encoded by this gene is a keratan sulfate proteoglycan that is involved in corneal transparency. Defects in this gene are a cause of autosomal recessive cornea plana 2 (CNA2).
REFERENCES
Aldave, A.J., et al. Invest. Ophthalmol. Vis. Sci. 51(8):4006-4012(2010) Dimasi, D.P., et al. Mol. Vis. 16, 562-569 (2010) : Wheeler, H.E., et al. PLoS Genet. 5 (10), E1000685 (2009) : Melrose, J., et al. Arthritis Res. Ther. 10 (4), R79 (2008) : Liskova, P., et al. Mol. Vis. 13, 1339-1347 (2007) :
